0.3102 USD
-0.11 (-25.84%)
0.3161 USD
+0.01 (+1.9%)
We assign a fundamental rating of 1 out of 10 to THMO. THMO was compared to 188 industry peers in the Health Care Equipment & Supplies industry. THMO has a bad profitability rating. Also its financial health evaluation is rather negative. THMO has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year THMO has reported negative net income.
THMO had a negative operating cash flow in the past year.
In the past 5 years THMO always reported negative net income.
In the past 5 years THMO always reported negative operating cash flow.
1.2 Ratios
THMO has a worse Return On Assets (-146.23%) than 89.47% of its industry peers.
THMO has a worse Return On Equity (-1512.82%) than 88.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -146.23% | ||
| ROE | -1512.82% | ||
| ROIC | N/A |
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 21.18%, THMO is not doing good in the industry: 80.53% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of THMO has declined.
The Profit Margin and Operating Margin are not available for THMO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
2. Health
2.1 Basic Checks
THMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, THMO has more shares outstanding
The number of shares outstanding for THMO has been increased compared to 5 years ago.
The debt/assets ratio for THMO is higher compared to a year ago.
2.2 Solvency
THMO has an Altman-Z score of -41.04. This is a bad value and indicates that THMO is not financially healthy and even has some risk of bankruptcy.
THMO has a worse Altman-Z score (-41.04) than 93.68% of its industry peers.
THMO has a Debt/Equity ratio of 4.31. This is a high value indicating a heavy dependency on external financing.
THMO's Debt to Equity ratio of 4.31 is on the low side compared to the rest of the industry. THMO is outperformed by 89.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.31 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -41.04 |
ROIC/WACCN/A
WACC17.38%
2.3 Liquidity
THMO has a Current Ratio of 0.52. This is a bad value and indicates that THMO is not financially healthy enough and could expect problems in meeting its short term obligations.
THMO has a worse Current ratio (0.52) than 96.84% of its industry peers.
THMO has a Quick Ratio of 0.52. This is a bad value and indicates that THMO is not financially healthy enough and could expect problems in meeting its short term obligations.
THMO has a Quick ratio of 0.37. This is amonst the worse of the industry: THMO underperforms 97.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 76.70% over the past year.
The Revenue has decreased by -7.66% in the past year.
The Revenue has been decreasing by -0.47% on average over the past years.
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%
3.2 Future
Based on estimates for the next years, THMO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.39% on average per year.
The Revenue is expected to grow by 20.88% on average over the next years. This is a very strong growth
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for THMO. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 1.52 indicates a rather cheap valuation of THMO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of THMO indicates a rather cheap valuation: THMO is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.40. THMO is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1.52 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
THMO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as THMO's earnings are expected to grow with 27.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.3%
EPS Next 3Y27.71%
5. Dividend
5.1 Amount
No dividends for THMO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.3102
-0.11 (-25.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.47M
Revenue(TTM)9.60M
Net Income(TTM)-14.75M
Analysts82.86
Price Target5.1 (1544.1%)
Short Float %0.01%
Short Ratio0
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9460.78%
Min EPS beat(2)-14311.8%
Max EPS beat(2)-4609.8%
EPS beat(4)0
Avg EPS beat(4)-7128.85%
Min EPS beat(4)-14311.8%
Max EPS beat(4)-572.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.48%
Min Revenue beat(2)-33.57%
Max Revenue beat(2)-29.39%
Revenue beat(4)0
Avg Revenue beat(4)-36.28%
Min Revenue beat(4)-51.56%
Max Revenue beat(4)-29.39%
Revenue beat(8)0
Avg Revenue beat(8)-30.38%
Revenue beat(12)2
Avg Revenue beat(12)-26.36%
Revenue beat(16)2
Avg Revenue beat(16)-30.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1.52 | ||
| P/S | 0.26 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.53 | ||
| P/tB | 2.53 | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.28
EYN/A
EPS(NY)0.2
Fwd EY65.76%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS1.21
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -146.23% | ||
| ROE | -1512.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.18% | ||
| FCFM | N/A |
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
F-Score3
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.31 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 81.17% | ||
| Cap/Sales | 10.24% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | -41.04 |
F-Score3
WACC17.38%
ROIC/WACCN/A
Cap/Depr(3y)69.46%
Cap/Depr(5y)46.66%
Cap/Sales(3y)7.71%
Cap/Sales(5y)4.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%
EBIT growth 1Y-0.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.2%
OCF growth 3YN/A
OCF growth 5YN/A
THERMOGENESIS HOLDINGS INC / THMO FAQ
What is the ChartMill fundamental rating of THERMOGENESIS HOLDINGS INC (THMO) stock?
ChartMill assigns a fundamental rating of 1 / 10 to THMO.
What is the valuation status of THERMOGENESIS HOLDINGS INC (THMO) stock?
ChartMill assigns a valuation rating of 4 / 10 to THERMOGENESIS HOLDINGS INC (THMO). This can be considered as Fairly Valued.
What is the profitability of THMO stock?
THERMOGENESIS HOLDINGS INC (THMO) has a profitability rating of 0 / 10.
What is the financial health of THERMOGENESIS HOLDINGS INC (THMO) stock?
The financial health rating of THERMOGENESIS HOLDINGS INC (THMO) is 0 / 10.
What is the earnings growth outlook for THERMOGENESIS HOLDINGS INC?
The Earnings per Share (EPS) of THERMOGENESIS HOLDINGS INC (THMO) is expected to grow by 102.13% in the next year.